Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Study Status entry was added for 2026-05-22 (submission 2026-05-19, version 21) and an older 2025-11-21 entry was removed, reflecting updated tracking of the trial's status.SummaryDifference0.3%

- Check20 days agoChange DetectedNew revision v3.5.4 is added to the record history, replacing the prior v3.5.3 entry. This reflects an update to the page’s release notes/versioning rather than changes to the study content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s display/versioning rather than the underlying clinical trial record content.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded Revision: v3.5.2 to the history. Deleted Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check63 days agoChange DetectedA new version entry was added on 2025-11-20 showing updated study status and recruitment details. The history now reflects the latest changes to the trial record.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision history now includes the addition of v3.5.0 and the deletion of v3.4.3.SummaryDifference0.1%

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.